Italian Prosecutor: Stem Cell Group Is a ‘Criminal Organization’

first_imgROME—After a 4-year investigation, a public prosecutor in Turin has delivered a withering indictment about a controversial stem cell therapy provided by the Stamina Foundation in Italy. The report, issued on Wednesday, describes Davide Vannoni, who introduced the treatment in Italy, as the head of a criminal organization that has defrauded about a thousand patients since 2006 by administering a dangerous and unapproved treatment in exchange for money.Prosecutor Raffaele Guariniello accuses 19 others as well; they include physicians, members of ethics committees, and directors at three public hospitals where Vannoni treated his patients, as well as the owner of a drug company, two foreign scientists, and the head of the Department of Research and Clinical Trials at AIFA, the Italian Medicines Agency.Vannoni has asked for up to €48,000 per treatment and €10,000 per year to store cells extracted from adults and children, the report says; his treatments exposed patients to serious risks, it concludes, including the risk of infection, severe bleeding, spinal cord injury, cancer, and ischemia. The report identifies a series of problems with the treatment. No preclinical and clinical studies were done, for instance; Vannoni’s team processed, handled, and injected cells under nonsterile conditions; and “bovine serum with no specified origin” was used as a culture medium. Patients “were turned into guinea pigs,” the report states.Sign up for our daily newsletterGet more great content like this delivered right to you!Country *AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Democratic Republic of theCook IslandsCosta RicaCote D’IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and Mcdonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People’s Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, The Former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexicoMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalestinianPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarReunionRomaniaRussian FederationRWANDASaint Barthélemy Saint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweI also wish to receive emails from AAAS/Science and Science advertisers, including information on products, services and special offers which may include but are not limited to news, careers information & upcoming events.Required fields are included by an asterisk(*)A judge must now decide whether the accusations warrant a trial. ScienceInsider could not reach Vannoni for comment. In the Italian newspaper La Repubblica, Vannoni said that he had expected the charges but said they were unfounded. “I have the documents to prove it and I’ll defend my self; 180 civil judges have already proven us right” by ruling that patients have a right to get the treatment, the paper quoted him as saying.Vannoni, who has a degree in philosophy and was a psychology professor at the University of Udine, is now president of the Stamina Foundation in Turin. He rose to national fame in Italy in 2012, when a popular TV show named The Hyenas claimed that he had cured people of neurodegenerative diseases including ALS, Parkinson’s, and Alzheimer’s, as well as several rare diseases affecting both adults and children. Soon, patients began seeking out the therapy.The treatments were administered at various locations. In 2011, Vannoni signed an agreement with the Spedali Civili Hospital in Brescia to treat 12 patients there. According to the report, some other patients were secretly treated at the Burlo Garofolo Hospital in Trieste. Vannoni also had patients treated in beauty centers in San Marino, a tiny republic surrounded by Italy, and even in the basement of a house in Turin, Guariniello writes.The 69-page report says Vannoni had a well-developed strategy that aimed to bypass the law on stem cell therapies, take the treatment to public hospitals, get the Italian government to pay for it, and expand the business around the world. In addition, he actively pushed patients to go to court to claim the right to be treated, the report says.Physicians at the hospital in Brescia were in the dark about the details of the treatment administered there; the report says they used to temporarily leave the lab because a Stamina Foundation biologist “had to add a secret ingredient to the stem cells” that supposedly helped the cells develop into neurons. “What the dossier claims is staggering,” says Michele De Luca, director of the Centre for Regenerative Medicine “Stefano Ferrari” in Modena, Italy. “It adds a sense of serious danger to the scientific inconsistency of the Stamina method which we were already aware of. We will wait, however, for justice to take its course.”The report may not be the end for Stamina’s treatment. Italy’s health minister, Beatrice Lorenzin, has already said that a scientific review of the method needs to proceed as planned.The review is the result of a political intervention. In 2012, AIFA and the National Transplant Center shut down Stamina’s activities after an inspection at the Brescia hospital found several serious problems with the lab and treatment. Following public protests, the Italian Parliament in May 2013 adopted a law ordering the government to design and fund a proper clinical trial of Stamina’s method. In September, however, a panel set up to investigate the method said there was no scientific basis for a trial. (The prosecutor’s report says that the documents Vannoni provided to the panel were produced by a medicine student who relied mainly on Wikipedia.)Vannoni successfully appealed the committee’s rejection in court, arguing that some of its members weren’t impartial. Lorenzin then nominated a new committee that is set to review the method soon. That panel could still propose a clinical study.But Amedeo Santosuosso, chair of the European Centre for Law, Science and New Technologies of the University of Pavia and a member of the first panel, hopes the saga will end before then. “At this point the minister should have the moral and political strength to take the right decision and put to a definitive end the whole story,” he says. “This is one of the darkest chapters in the history of medicine of this country.”last_img read more

Should Buyers Beware or Start Celebrating

first_img After years of steadily increasing values, home price reductions are on the rise. In fact, the share of U.S. homes listed for sale with at least one price cut is at its highest level since 2014—“more evidence of a market that may finally be tilting in homebuyers’ favor,” states a new report by Trulia.According to Trulia, price reduction was largely unchanged this year until July and August, climbing to 17 percent from one month to the next. That was the highest national rate for reductions since August 2014. Compared to August 2017 this August saw its share of listings with a price cut rise in 63 of the 100 largest metros.“Coupled with home price growth that has begun to slow, and inventory levels that are creeping back up in some places, a higher rate of price cuts could be a critical third confirmation that things may finally be shifting in buyers’ favor,” the report stated.According to the report, the 12 months ending August 2018 saw a median nationwide reduction of 2.6 percent off listing prices.Pricier neighborhoods saw listing prices drop more often than less expensive neighborhoods, Trulia reported. This was especially prevalent in Camden, New Jersey, and Raleigh.“Raleigh’s more expensive Glenwood and Five Points neighborhoods, where median home values are currently $676,500 and $519,400, respectively (compared to a metro-wide median of $258,692), have seen 18.9 percent and 16.7 percent of their listings go through at least one price cut over the past year,” the report stated. “Meanwhile, in the less expensive neighborhoods of South Raleigh and Southeast Raleigh, only 5.8 percent and 6.7 percent of listings have had a price cut in the past 12 months.”Camden saw similar numbers. According to Trulia, 21.5 percent of listings in Springdale, the city’s most expensive neighborhood, had a price cut in the year ended in August; meanwhile, in Bergen Square, among the city’s least expensive areas, just 8.6 percent of listings had a price cut over the same time.The caveat: “The growing prevalence of price reductions is likely to be welcomed by home shoppers, but the news could be tempered somewhat by the fact the median price reduction itself is getting smaller,” the report stated.Across the 12 months ending August 2018, the median reduction nationwide knocked 2.6 percent off the listing price, the report stated. During the same period in 2011-2012, the median reduction was 4 percent.The median percent decrease of a price reduction today, the report concluded, is less than the median price reduction at the outset of the recovery in 97 of the 100 largest metros Trulia analyzed. November 23, 2018 1,841 Views in Daily Dose, Data, Featured, Media, News Should Buyers Beware or Start Celebrating?center_img Affordability Camden Home Prices Homebuyers Housing Market housing trends Raleigh Trulia 2018-11-23 Scott_Morgan Sharelast_img read more